Alreem Al-Nabti is a Clinical Assistant Professor of Dermatology at Weill Cornell Medical College and an Assistant Attending Dermatologist at NewYork-Presbyterian Hospital. Board-certified by the American Board of Dermatology, her clinical practice spans pediatric, adolescent, and adult dermatology with a focus on general and cosmetic dermatology. Education: M.D. from Weill Cornell Medical College-Qatar (2016) Her research interests include pediatric skin diseases , hemangioma treatment , and AI applications in dermatology patient education . Recent publications highlight her work on rare autoimmune dermatoses, vascular tumors in children, and digital health innovations. Dr. Al-Nabti's clinical expertise covers acne, eczema, skin lesions, and cosmetic procedures like laser surgery, with a special emphasis on early detection of systemic diseases through dermatological symptoms.
Agustín España Alonso is the Director of the Department of Dermatology at the University of Navarra Clinic, where he specializes in Medical-Surgical and Venereological Dermatology. He is a Professor at the Faculty of Medicine of the University of Navarra since 2014 and was previously Vice Dean of the Faculty in 2003. His clinical focus is on autoimmune blistering diseases, and he has contributed extensively to research and education in dermatology. Graduated in Medicine from the Autonomous University of Madrid (1984) Specialized in Dermatology at Ramón y Cajal Hospital (1986-1989) PhD in Medicine from the Autonomous University of Madrid (1990) Clinical Research Fellow in Immunodermatology at the Medical College of Wisconsin, USA (1994-1995) His research interests include: Autoimmune blistering diseases (e.g., pemphigus vulgaris, bullous pemphigoid) Atopic dermatitis Connective tissue diseases (e.g., lupus erythematosus, scleroderma) Hyperhidrosis Inflammatory skin diseases of immunological origin He has led 6 research projects as Principal Investigator, participated in 2 as collaborator, and developed 6 research protocols. He has authored 80 international journal articles, edited 5 books, and written 33 book chapters, while directing 6 doctoral theses. He is accredited as a University Professor by Spain’s Ministry of Education. Member of the Spanish Academy of Dermatology and Syphiliography (since 1998) Member of the American Academy of Dermatology (since 2002) President of the Basque-Navarre-Aragonese-Riojana Section of the Spanish Academy of Dermatology and Venereology (2003–2007) Member of the Editorial Committee of PIEL Journal and Editorial Board of Actas Dermo-Sifiliográficas Journal
Michel Gilliet is a Full Professor at the Faculty of Biology and Medicine, University of Lausanne (UNIL), and Head of the Department of Dermatology and Venereology at the Centre Hospitalier Universitaire Vaudois (CHUV). He specializes in cutaneous immune responses and the development of immunotherapies for melanoma and other inflammatory skin diseases. Full Professor, Faculty of Biology and Medicine, University of Lausanne (since December 1, 2010) Head, Department of Dermatology and Venereology, CHUV Former Associate Professor and co-Director, Cancer Inflammation Center, MD Anderson Cancer Center Education: MD, University of Zurich (1995) FMH in Dermatology, University of Zurich (2004) Postdoctoral Research, DNAX Research Institute, Palo Alto (1999–2001) Michel Gilliet's research centers on the immunological mechanisms underlying skin diseases. He is particularly known for his work on antimicrobial peptides and their role in the pathogenesis of psoriasis, lupus, and other inflammatory skin conditions . His work bridges fundamental immunology and clinical applications, leading to novel immunotherapeutic strategies currently tested in clinical trials in the United States. He has contributed significantly to understanding melanoma monitoring through immunotherapy protocols . Although specific publications are not listed in the source text, his research output is extensive and published in top-tier journals such as Nature . His editorial role as Associate Editor of the Journal of Investigative Dermatology since 2007 highlights his academic leadership. His work shows a consistent focus on translational immunodermatology, combining clinical insight with experimental discovery. Scientific Awards: Recipient of multiple Swiss and international awards and distinctions Michel Gilliet has played a key role in advancing dermatology research in Lausanne, promoting interdisciplinary collaboration and strengthening ties between academic and regional dermatologists. He established the ASTRAL registry (though this may be conflated with Patrik Michel; clarification needed), but his leadership in immunology research is well documented. He has been involved in numerous research grants and collaborative projects, particularly in cancer immunology and inflammation. Laboratories and Research Teams: He leads a research group focused on cutaneous immunology and immunotherapy at UNIL-CHUV, integrating clinical dermatology with experimental immunology. His team investigates immune pathways in skin cancers and autoimmune dermatoses, aiming to develop targeted therapies.
Dr. Henry C. Hsia is a Professor of Surgery (Plastics) at Yale School of Medicine and Founding Director of the Yale Regenerative Wound Healing Center. He specializes in plastic and reconstructive surgery with a focus on innovative wound healing therapies. His research bridges clinical practice and basic science, emphasizing translational approaches to address complex wounds. Education: B.A., Harvard University (Biology & Anthropology, 1990) M.D., Yale University School of Medicine (1996) Residency: Yale-New Haven Hospital (Surgery, 1999–2002) Postdoctoral Fellowship: Princeton University (Molecular Biology, NIH-funded, 2005) Research Interests: Dr. Hsia investigates biological mechanisms of wound healing, including roles of extracellular matrix, fibroblast heterogeneity, and macrophage interactions. His lab develops biomaterials (e.g., alginate hydrogels, collagen scaffolds) and cell-based therapies to enhance regenerative outcomes. Key themes include: Biomedical engineering for wound care Impact of lifestyle factors (e.g., smoking, diet) on healing Translational strategies for diabetic and chronic wounds Grants & Collaborations: Leads multidisciplinary initiatives at Yale and VA Connecticut Healthcare System. Collaborates with experts in biomedical engineering (e.g., Valerie Horsley, Themis Kyriakides) and clinical teams to advance therapies. Labs/Teams: Directs the Yale Regenerative Wound Healing Center, fostering collaborations between surgeons, bioengineers, and immunologists to accelerate clinical translation.
Mark J Scharf, MD, is a Professor of Medicine at the UMass Chan Medical School , affiliated with the T.H. Chan School of Medicine and the Dermatology Department . His research spans lasers, photomedicine, Mohs surgery, and marine dermatology. Education: Bachelor of Arts in Biological Sciences, University of Chicago (1978) Doctor of Medicine, Emory University School of Medicine Research Interests: Specializing in laser-based dermatological care , phototherapy, and Mohs surgery, Dr. Scharf's work bridges clinical practice and technological innovation. His focus on marine dermatology addresses unique environmental skin challenges, while his medical education contributions highlight his commitment to academic mentorship. Publications: 11 recent articles (1994–2022) emphasize dermatological lasers, autoimmune skin diseases, and drug-induced dermatoses Highly cited work on mindfulness-based psoriasis treatment (1998, 100+ citations)
Curdin Conrad is Associate Professor at the University of Lausanne (UNIL) and Chief Physician at the Department of Dermatology and Venereology at CHUV. He directs the high-volume outpatient clinic, handling over 45,000 consultations annually, and leads the internationally recognized Psoriasis Center, a key site for clinical and translational research. His research focuses on the fundamental mechanisms of psoriasis and immunodermatoses, combining animal models, biobanks, and clinical trials. His work has contributed to the development of novel immunotherapies and biotherapies now in clinical use or nearing market. He is a member of the International Psoriasis Council, an elite group of the world’s top 100 psoriasis experts. He was appointed Associate Professor at UNIL on March 1, 2018, and is actively involved in pre-graduate dermatology training and research governance as a member of the FBM Research Commission. His leadership has driven the expansion and reorganization of dermatological services at CHUV, fostering collaboration across departments such as rheumatology, immunology, and gastroenterology. Curdin Conrad’s work is supported by significant external funding and has been published in top-tier journals like Nature Medicine . He leads multiple investigator-initiated and international clinical trials, positioning his unit as a leader in dermatological innovation. 1974: Born in Zurich, originally from Grisons 2001: Federal Diploma of Medicine, University of Zurich 2002: MD, University of Zurich 2002–2003: Postgraduate Course in Experimental Medicine and Biology, University Hospital Zurich 2003–2008: Assistant, Department of Dermatology, University Hospital Zurich 2007: Specialist title in dermatology and venereology 2008–2010: SNSF Postdoctoral Fellowship, MD Anderson Cancer Center, Houston, USA 2011: Head of Clinic, CHUV; Privat-docent, UNIL 2012: Assistant Physician, Lecturer, and Researcher at UNIL 2017: Chief Physician, CHUV 2018: Associate Professor, UNIL Throughout his career, Conrad has demonstrated a strong commitment to advancing dermatological science and mentoring future talent. His leadership in both clinical and research settings underscores his significant contributions to the field of dermatology and academic medicine.
Richard J. Antaya is a Professor of Dermatology, Pediatrics and Nursing at Yale School of Medicine, where he serves as Director of Pediatric Dermatology, Fellowship Director for Pediatric Dermatology, and Medical Director of Yale Dermatology New Haven. With over 25 years of clinical experience, Dr. Antaya specializes in the diagnosis and management of all skin diseases affecting infants, children, and adolescents. B.S. in Chemistry from Rensselaer Polytechnic Institute (1985) M.D. from Tufts University (1989) Pediatrics Residency at Tripler Army Medical Center (1992) Dermatology Residency at Duke University Board Certified in Dermatology (1998), Pediatrics (1992), and Pediatric Dermatology (2004) Dr. Antaya's research focuses on pediatric skin disorders, particularly vascular anomalies, atopic dermatitis, genetic skin conditions, and laser treatments for vascular lesions. He is the founder and past Chair of Yale Medicine's multidisciplinary Vascular Anomalies and Malformations Program (VAMP) and sees patients at the Hereditary Hemorrhagic Telangiectasia (HHT) Center. He runs a weekly pediatric vascular anomalies clinic offering pulsed dye laser surgery to correct vascular lesions, significantly improving children's appearance and confidence levels. His recent publications demonstrate a strong focus on the mental health impact of pediatric skin conditions, novel treatments for atopic dermatitis including biologic medications, and vascular malformations. Dr. Antaya is currently conducting clinical trials for adolescents with severe atopic dermatitis using new biologic medications and for children with chilblains. Best Doctors in America (2020) America's Top Doctors (2020) Presidential Citation Award from American Academy of Dermatology (2018) Connecticut Magazine Top Docs (2023) Dr. Antaya teaches medical students, physician assistant students, advanced practice nursing students, and residents in both dermatology and pediatrics. He is deeply committed to patient care, stating: 'Being able to help patients find relief from all varieties of skin, hair, nail and sweat gland disorders is incredibly gratifying and is my life mission. I am passionate about forming strong relationships with my patients and their families. I enjoy being their advocate and advisor to assist them in navigating the complexities of modern medicine.' He is actively involved in the Pediatric Multidisciplinary Neurocutaneous Clinic and has established a robust clinical practice and research program focused on improving outcomes for children with complex dermatological conditions.
Lesley Rhodes is a Professor of Dermatology and Photobiology at the University of Manchester and an Honorary Consultant Dermatologist at Salford Royal Hospital. She directs the Photobiology Unit and leads the Photodermatoses Research Programme. Her work focuses on photodermatoses, vitamin D synthesis, and photoprotection strategies. Education: BSc from University College London, MB BS from King's College London, and an MD from the University of Liverpool. Clinical training included roles at Royal Liverpool University Hospitals and the Wellman Laboratories of Photomedicine in Boston. Research interests encompass solar UV effects, mechanisms of photosensitivity disorders, and the balance between sunlight's health benefits and risks. Key contributions include defining vitamin D synthesis requirements and advancing photoprotective measures like afamelanotide. Major awards include the European Society for Photobiology Medal (2019) and the Ian Magnus Memorial Lecture (2022). She advises international bodies like the United Nations Environment Programme and the UK Department of Health. Supervised 26 postgraduate researchers (7 current) and secured over £11M in grants from NIHR, Cancer Research UK, and others. Collaborations span Europe, USA, and Australasia.
Sa Rang Kim, MD is an Assistant Professor in the Department of Dermatology at Yale School of Medicine, specializing in complex dermatological conditions with a focus on cutaneous lymphoma, autoimmune skin disorders, and dermatologic surgery. Her clinical practice integrates advanced diagnostic techniques with innovative therapeutic approaches for challenging cases. Dr. Kim completed her medical training at Yale School of Medicine (MD, 2019), followed by an internship at Yale New Haven Hospital (2020) and residency at Yale New Haven Hospital (2023). She holds board certification in Dermatology from the American Board of Dermatology (2023) and earned her BS (Hon) in Cell and Molecular Biology and Human Biology from the University of Toronto (2014). Her research program centers on improving diagnostic accuracy and therapeutic outcomes for patients with cutaneous T-cell lymphoma, systemic sclerosis-related skin manifestations, and challenging inflammatory dermatoses. She has pioneered work in differentiating palmoplantar psoriasis from eczema using molecular markers and developed novel treatment protocols for microstomia in scleroderma patients. Current investigations include optimizing laser therapies for ethnic skin types and advancing diagnostic criteria for rare nail disorders. Dr. Kim's collaborative research network includes prominent Yale dermatologists Michael Girardi, Kathleen Cook Suozzi, and Amanda Zubek, with whom she has published extensively on cutaneous lymphoma diagnostics, scleroderma management, and inflammatory skin disease differentiation. Her work demonstrates consistent translational impact, moving from basic histopathological observations to clinical applications. Cum laude, Yale School of Medicine (2019) As a clinician-scientist, Dr. Kim maintains active involvement in resident education and clinical trial development. Her laboratory work combines advanced molecular techniques with clinical observation to develop more precise diagnostic criteria for challenging dermatological conditions. She is currently developing predictive models for treatment response in cutaneous lymphoma and investigating novel applications of existing therapies for scleroderma-related facial complications.
Luke S. Johnson is a Clinical Associate Professor in the Dermatology department and an Adjunct Assistant Professor in Pediatrics at the University of Utah . A board-certified dermatologist with specialized training in Pediatric Dermatology, he treats both adults and children for conditions ranging from acne and eczema to rare disorders like immunodeficiency states and unusual birthmarks. Education : MD from University of Pittsburgh School of Medicine Fellowship in Pediatric Dermatology at Oregon Health & Science University Residency in Dermatology at Texas Tech University Health Sciences Center Internship at University of Pittsburgh Medical Center Postbaccalaureate studies at Salt Lake Community College and University of Utah B.S. in Psychology with minor in Theatre Arts from Westminster College His clinical methods integrate lifestyle recommendations, medications, surgery, and laser techniques. Recent research focuses on skin cancer recurrence , hair regrowth therapies , and infectious dermatoses in immunocompromised patients , including collaborations on AI-assisted alopecia treatments and HPV-related pathologies. Board Certifications : American Board of Dermatology American Board of Dermatology (Pediatric Dermatology Subspecialty) National Board of Medical Examiners
Kristin M. Leiferman, MD , is a Professor of Dermatology and Adjunct Professor of Pathology at the University of Utah . She serves as Co-Director of the Immunodermatology Laboratory and specializes in immune-mediated skin diseases , particularly allergic skin diseases and autoimmune blistering diseases . Board-certified in Dermatology and Dermatological Immunology/Diagnostic and Laboratory Immunology , she has analyzed thousands of specimens for blistering disease diagnosis. Undergraduate: Biology, University of Minnesota (B.S.) Medical: Mayo Medical School (M.D.) Residency: Mayo Clinic (Dermatology) Her research focuses on allergy-related inflammation , mast cell and eosinophil disorders, and the diagnosis of autoimmune skin and mucosal diseases . Her publications span hypereosinophilic syndromes , blistering disease mechanisms , and inflammatory mediator detection . Dr. Leiferman contributes to clinical immunology and dermatological diagnostics , with a career-long emphasis on bridging laboratory immunology and patient care . She leads the Immunodermatology Laboratory at the University of Utah, advancing diagnostic protocols and therapeutic approaches for complex skin conditions.
John J. Zone, MD is a Professor in the Department of Dermatology at the University of Utah, with adjunct appointments in Pathology. Specializing in autoimmune blistering diseases, he maintains dual research and clinical laboratories focused on diagnosis, treatment, and immunopathogenesis of conditions including dermatitis herpetiformis, pemphigus, and linear IgA disease. Board Certified: Dermatology, Immunodermatology, Internal Medicine Key Research Areas: Autoimmune Skin Disorders, Gluten-related Dermatosis, Transglutaminase Antibodies His work bridges clinical dermatology and immunological research, with significant contributions to understanding the molecular mechanisms of IgA-mediated skin diseases. Dr. Zone has published extensively on topics including: Autoimmune bullous disease pathogenesis Celiac disease-dermatitis herpetiformis connections Neutrophil adherence mechanisms in IgA dermatoses Therapeutic approaches for refractory cases Scientific contributions include: Identifying the 97 kDa linear IgA bullous disease antigen Characterizing IgA antibody responses in cutaneous immune disorders Developing mouse models for autoimmune skin disease research
Victor Kokta is an Associate Clinical Professor in the Department of Pathology and Cell Biology at the Faculty of Medicine, University of Montreal. He serves as a pathologist and researcher at CHU Ste-Justine, with particular expertise in pediatric dermatopathology. His clinical and research work focuses on pediatric melanocytic tumors and vascular tumors/malformations. Dr. Kokta completed his medical training at the University of Sherbrooke, specialized in anatomopathology at the University of Montreal, and pursued sub-specialization in adult and pediatric dermatopathology at New York Presbyterian - The University Hospitals of Columbia and Cornell under Dr. N. Scott McNutt and Dr. Klauss Busam, completing this training in 2001. He is affiliated with the Azrieli Research Center at CHU Sainte-Justine. His research interests center on pediatric melanocytic tumors (including Spitz nevi and pediatric melanomas) and pediatric vascular tumors/malformations. Analysis of his recent publications reveals a consistent focus on rare pediatric skin conditions, genetic disorders with cutaneous manifestations, and innovative therapeutic approaches for complex dermatological conditions. His work often involves multidisciplinary collaboration across dermatology, pathology, genetics, and immunology. Fellow of the Royal College of Physicians and Surgeons of Canada (2000) Member of the College of Physicians of Quebec (2001) First prize for research presentation at Dalhousie University diabetes symposium (1991) Dr. Kokta has been actively supervising internships in dermatopathology for pathology and dermatology residents at the University of Montreal since 2001 and collaborates extensively with teams in dermatology, surgery, radiology, and plastic surgery. His laboratory work at CHU Ste-Justine focuses on the pathological analysis of complex pediatric skin conditions, particularly those involving melanocytic and vascular components.
Jean Bolognia is Professor of Dermatology and Vice Chair of Faculty Affairs at Yale School of Medicine, Yale University. She specializes in medical and pediatric dermatology with clinical focus on melanocytic nevi, melanoma, and cutaneous side effects of chemotherapy. Dr. Bolognia serves as senior editor of the authoritative textbooks Dermatology (4th edition) and Dermatology Essentials . Her education includes an MD from Yale University (1980), internship at Yale-New Haven Hospital (1981), residency at Yale-New Haven Hospital (1985), and postdoctoral fellowship at Yale University (1987). Research interests focus on dermatopathology correlations of melanocytic lesions, cutaneous oncology, drug reactions, and rare dermatologic conditions. Her investigations span clinical dermatology, skin cancer diagnostics, and inflammatory skin disorders with emphasis on translational applications. Publications demonstrate expertise across dermatologic subspecialties including cutaneous oncology, autoimmune disorders, lymphoproliferative conditions, infectious manifestations, and medical education. Recent works emphasize evidence-based management of complex dermatologic conditions. Scientific Awards & Honors: Medal for Achievements in Global Dermatology (International League of Dermatological Societies, 2023) Alvan R. Feinstein Award (Yale University, 2023) Distinguished Clinical Career Award (Yale University, 2020) Gold Medal (American Academy of Dermatology, 2019) Lifetime Achievement Award (Medical Dermatology Society, 2016) Honorary memberships in 12+ international dermatological societies Dr. Bolognia has held presidential leadership positions in the Medical Dermatology Society, Women's Dermatologic Society, and American Dermatological Association. She continues to advance dermatologic education through textbook authorship and clinical training.
Giampiero Girolomoni serves as Professor of Dermatology and Head of the Dermatology Section within the Department of Medicine at the University of Verona School of Medicine, Italy. His career spans clinical dermatology, academic leadership, and translational research focused on inflammatory skin disorders. Dr. Girolomoni completed his medical training and dermatology residency at the University of Modena, followed by research fellowship experience. His current academic appointment reflects deep expertise in both clinical practice and scientific investigation within dermatology. His research concentrates on: Psoriasis pathogenesis with emphasis on immune-keratinocyte interactions Cardio-metabolic comorbidities in chronic inflammatory skin diseases Therapeutic strategies for moderate-to-severe psoriasis Immunological mechanisms underlying inflammatory skin conditions Analysis of his 2015-2020 publications reveals consistent focus on psoriasis immunopathology and its systemic implications, bridging basic immunology (neutrophil function, cytokine networks) with clinical management challenges. His work demonstrates particular attention to patient subgroups with metabolic complications. Professional collaborations span major Italian research institutions including Humanitas Research Hospital, Civil Hospital of Brescia, and Institute of Immaculate Dermatology in Rome, reflecting integration within national dermatology research networks. While specific grant details aren't provided, his publication output indicates sustained research activity in psoriasis therapeutics and pathogenesis.
